Clinical trials
Phase 2 Carcinoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Steba Biotech S.A. | 3 |
| Sanofi | 2 |
| Acrotech Biopharma Inc. | 1 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Leon Berard | 1 |
| Institut Bergonié | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 25 |
| Neoplasms | 9 |
| Neoplasms by Site | 6 |
| Adenocarcinoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Diseases | 4 |
| Digestive System Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Neoplasms by Histologic Type | 3 |
| Neoplasms, Glandular and Epithelial | 3 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.